Skip to content
Screener

Vericel VCEL Q2 2025 earnings

Reported July 31, 2025 · Before market open

Revenue$63.2MMiss by $1.3M
EPS-$0.01Beat by $0.03
Revenue estimate$64.6M
EPS estimate-$0.04

Next report

Nov 5, 2026 (in a month)
Revenue estimate$78.0M
EPS estimate$0.02

Financials

Q2 2025

Income statement

See full
Revenue$63.2M+20.1%
Gross profit$46.6M+27.4%
Operating income-$2.0M+66.4%
Net income-$553.0K+88.2%
EPS (diluted)-$0.01+90.0%

Balance sheet

See full
Cash & equivalents$80.5M+6.2%
Total debt$100.4M+5.1%
Total equity$306.8M+26.3%
Total assets$435.6M+15.6%

Cash flow

See full
Operating cash flow$8.2M-55.7%
CapEx$8.1M-51.5%
Free cash flow$81.0K—

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$2.18B-2.2%
Enterprise value$2.2B-2.1%
P/E307×—
P/S8.8×-1.6×

Profitability

See full
Gross margin73.5%+3.1pp
Operating margin0.5%—
Net margin2.9%—

Returns & leverage

See full
Return on equity2.6%—
Debt / equity0.3×-0.1×
Current ratio5×+0.5×

Segments

By product

See full
M A C I Implants and kits$53.5M+21.1%
MACI implants, kits, and instruments$39.4M+28.4%
Epicel$8.6M+11.0%
Biopsy kits$642.0K+30.5%

FAQ

When did Vericel report Q2 2025 earnings?
Vericel (VCEL) reported Q2 2025 earnings on July 31, 2025 before market open.
What were Vericel's Q2 2025 revenue and EPS?
Vericel reported revenue of $63.2M and eps of $-0.01 for Q2 2025.
Did Vericel beat estimates in Q2 2025?
Revenue missed the consensus estimate of $64.6M by $1.3M. EPS beat the consensus estimate of $-0.04 by $0.03.
How did Vericel's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 20.1% from $52.7M a year earlier and eps grew 90.0% from $-0.10.
Where can I find Vericel's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-036854) and the 10-Q periodic report (0001628280-25-036859) directly on SEC EDGAR. The filing index links above go to sec.gov.